Novo Nordisk A/S (NVO)
49.07
+2.71
(+5.85%)
USD |
NYSE |
Dec 10, 16:00
49.00
-0.07
(-0.14%)
After-Hours: 16:14
Novo Nordisk Market Cap: 218.04B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Evaxion AS | 40.81M |
| Ascendis Pharma A/S | 12.31B |
| Regeneron Pharmaceuticals, Inc. | 76.34B |
| Omeros Corp. | 796.92M |
| Viking Therapeutics, Inc. | 4.242B |
Market Cap Related Metrics
| PE Ratio | 14.29 |
| PS Ratio | 4.682 |
| PEG Ratio | 1.263 |
| Price to Book Value | 10.75 |
| Price to Free Cash Flow | 23.64 |
| Price | 49.07 |
| Earnings Yield | 7.00% |
| PEGY Ratio | 0.9500 |
| Operating PE Ratio | 11.04 |
| Normalized PE Ratio | 14.29 |